AzTrials
AzTrials

Preventing Blood Leakage of Bronchial CuffNCT01979640

Adequate Additional Bronchial Cuff Volume to Achieve Blood-tight Seal After Air-tight Seal in Double Lumen Tube

A study testing 39 Fr double lumen tube group, 37 Fr double lumen tube group and 35 Fr double lumen tube group in people with Preventing Blood Leakage of Bronchial Cuff, run by Seoul National University Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to find the adequate additional bronchial cuff volume after achievement of air-tight seal, that can achieve blood-tight seal(preventing leakage of blood through cuff) in double lumen tube Read more about this study

Who is it for?
Ages 20 to 85 years
What is being tested?
39 Fr double lumen tube group, 37 Fr double lumen tube group and 35 Fr double lumen tube group
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
132 participants
Where
1 siteSouth Korea
Study dates
Aug 2013to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients undergoing thoracic surgery under left lower decubitus position, using left sided double lumen tube
  • patient's left main bronchus size adequate for 35Fr, 37 Fr, 39 Fr double lumen tube

Who cannot join

  • dislocation or great movement of double lumen tube depth

Trial locations and contacts

1 site in 1 country.

Jae-Hyon Bahk, MD, PhD contact

82-2-2072-2818

bahkjh@snu.ac.kr

South Korea1 site, 1 recruiting
  • Seoul National University Hospital

    Seoul

    Jae-Hyon Bahk, MD, PhD, 82-2-2072-2818, bahkjh@snu.ac.kr

    Recruiting

Other trials in South Korea

About this study

The purpose of this study is to find the adequate additional bronchial cuff volume after achievement of air-tight seal, that can achieve blood-tight seal(preventing leakage of blood through cuff) in double lumen tube

Being tested
39 Fr double lumen tube group, 37 Fr double lumen tube group, 35 Fr double lumen tube group
Keywords
bronchial cuff, double lumen tube, blood tight seal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 39 Fr double lumen tube groupProcedure or surgery

    additional bronchial cuff volume is decided according to up-and-down biased coin design sequential method, by incremental volume of 0.1 ml

  • 37 Fr double lumen tube groupProcedure or surgery

    additional bronchial cuff volume is decided according to up-and-down biased coin design sequential method, by incremental volume of 0.1 ml

  • 35 Fr double lumen tube groupProcedure or surgery

    additional bronchial cuff volume is decided according to up-and-down biased coin design sequential method, by incremental volume of 0.1 ml

Study groups in NCT01979640
Study groupRoleWhat they receive
39 Fr double lumen groupExperimentalpatients are assigned to 35 Fr, 37 Fr, 39 Fr double lumen tube group according to their left main bronchus diameter measured by preoperative chest CT, to minimize difference between main bronchus diameter and bronchial tip diameter of double lumen tube
Receives: Procedure: 39 Fr double lumen tube group
37 Fr double lumen groupExperimentalpatients are assigned to 35 Fr, 37 Fr, 39 Fr double lumen tube group according to their left main bronchus diameter measured by preoperative chest CT, to minimize difference between main bronchus diameter and bronchial tip diameter of double lumen tube
Receives: Procedure: 37 Fr double lumen tube group
35 Fr double lumen tube groupExperimentalpatients are assigned to 35 Fr, 37 Fr, 39 Fr double lumen tube group according to their left main bronchus diameter measured by preoperative chest CT, to minimize difference between main bronchus diameter and bronchial tip diameter of double lumen tube
Receives: Procedure: 35 Fr double lumen tube group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. leakage of autologus blood through bronchial cuff

    Measured: 10, 20, 30 minutes after dripping of blood around bronchial cuff

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Nov 2013 (estimated)
  2. Study startAug 2013
  3. Primary completionDec 2016 (estimated)
  4. Study completionDec 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
132 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01979640
Sponsor's protocol ID
JHBahk_DLT_bloodtightseal
Status last verified
Apr 2016
First submitted
3 Nov 2013
Last updated
20 Apr 2016
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing 39 Fr double lumen tube group, 37 Fr double lumen tube group and 35 Fr double lumen tube group in people with Preventing Blood Leakage of Bronchial Cuff, run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jae-Hyon Bahk, MD, PhD (82-2-2072-2818, bahkjh@snu.ac.kr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

leakage of autologus blood through bronchial cuff (time frame: 10, 20, 30 minutes after dripping of blood around bronchial cuff). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in